Publications

Title

Author

Year

Inhibition of mycobacterial growth in vitro following primary but not secondary vaccination with Mycobacterium bovis BCG.

FLETCHER, HA; Tanner, R; Wallis, RS; Meyer, J; Manjaly, Z-R; Harris, S; Satti, I; Silver, RF; Hoft, D; KAMPMANN, B; Walker, KB; DOCKRELL, HM; Fruth, U; Barker, L; Brennan, MJ; McShane, H;

2013

Clinical and vaccine immunology, (2013).20 11 10.1128/CVI.00427-13.

Efficacy and effectiveness of seasonal and pandemic A (H1N1) 2009 influenza vaccines in low and middle income countries: a systematic review and meta-analysis.

Breteler, JK; Tam, JS; JIT, M; Ket, JC F; De Boer, MR;

2013

Vaccine, (2013).31 45 10.1016/j.vaccine.2013.08.056.

Effectiveness of inactivated influenza vaccines in preventing influenza-associated deaths and hospitalizations among Ontario residents aged ≥ 65 years: estimates with generalized linear models accounting for healthy vaccinee effects.

Ridenhour, BJ; Campitelli, MA; Kwong, JC; Rosella, LC; ARMSTRONG, BG; MANGTANI, P; Calzavara, AJ; Shay, DK;

2013

PloS one, (2013).8 10 10.1371/journal.pone.0076318.

The impact of specific and non-specific immunity on the ecology of Streptococcus pneumoniae and the implications for vaccination.

FLASCHE, S; EDMUNDS, WJ; MILLER, E; Goldblatt, D; Robertson, C; Choi, YH;

2013

Proceedings Biological sciences / The Royal Society, (2013).280 1771 10.1098/rspb.2013.1939.

Assessing optimal target populations for influenza vaccination programmes: an evidence synthesis and modelling study.

BAGUELIN, M; FLASCHE, S; CAMACHO, A; Demiris, N; MILLER, E; EDMUNDS, WJ;

2013

PLoS medicine, (2013).10 10 10.1371/journal.pmed.1001527.

Nasopharyngeal carriage of pneumococci four years after community-wide vaccination with PCV-7 in The Gambia: long-term evaluation of a cluster randomized trial.

ROCA, A; Dione, MM; BOJANG, A; Townend, J; Egere, U; Darboe, O; Howie, SR C; Hill, PC; Adegbola, RA; GREENWOOD, BM; ANTONIO, M;

2013

PLOS ONE, (2013).8 9 10.1371/journal.pone.0072198.

Effect of a serogroup A meningococcal conjugate vaccine (PsA-TT) on serogroup A meningococcal meningitis and carriage in Chad: a community study [corrected].

Daugla, DM; Gami, JP; Gamougam, K; Naibei, N; Mbainadji, L; Narbé, M; Toralta, J; Kodbesse, B; Ngadoua, C; Coldiron, ME; Fermon, F; Page, A-L; Djingarey, MH; Hugonnet, S; Harrison, OB; Rebbetts, LS; Tekletsion, Y; Watkins, ER; Hill, D; Caugant, DA; CHANDRAMOHAN, D; Hassan-King, M; MANIGART, O; NASCIMENTO, M; Woukeu, A; ... GREENWOOD, BM.

2013

Lancet, (2013).383 9911 10.1016/S0140-6736(13)61612-8.

Does a 10-valent pneumococcal-Haemophilus influenzae protein D conjugate vaccine prevent respiratory exacerbations in children with recurrent protracted bacterial bronchitis, chronic suppurative lung disease and bronchiectasis: protocol for a randomise...

O'Grady, K-AF; Grimwood, K; Cripps, A; MULHOLLAND, EK; Morris, P; Torzillo, PJ; Wood, N; Smith-Vaughan, H; Revell, A; Wilson, A; Van Asperen, P; Richmond, P; Thornton, R; Rablin, S; Chang, AB;

2013

Trials, (2013).14, 10.1186/1745-6215-14-282.

Systematic review and meta-analysis of the current evidence on the duration of protection by bacillus Calmette-Guérin vaccination against tuberculosis.

Abubakar, I; Pimpin, L; ARITI, C; Beynon, R; MANGTANI, P; Sterne, JA C; FINE, PE M; SMITH, PG; Lipman, M; Elliman, D; Watson, JM; Drumright, LN; Whiting, PF; VYNNYCKY, E; RODRIGUES, LC;

2013

Health technology assessment (Winchester, England), (2013).17 37 10.3310/hta17370.

[Medium-term acceptability of HIV vaccine clinical trials in Burkina Faso: stakeholders' perceptions].

Berthé, A; Traore, I; Berthé-Sanou, L; Somé, J; Salouka, S; Rouamba, J; MAYAUD, P; Nagot, N; Meda, N;

2013

Sante publique (Vandoeuvre-les-Nancy, France), (2013).25 5 10.3917/spub.135.0675.